COPD Treatment Breo Ellipta Now Available in US
BREO ELLIPTA, a once-daily inhaled ICS/LABA for chronic obstructive pulmonary disease (COPD), is now available to pharmacies throughout the U.S., according to GlaxoSmithKline and Theravance Inc.
BREO ELLIPTA, a once-daily inhaled ICS/LABA for chronic obstructive pulmonary disease (COPD), is now available to pharmacies throughout the U.S., according to GlaxoSmithKline and Theravance Inc.